This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Sep 16:351:h4629.

doi: 10.1136/bmj.h4629.

No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility

PMID: 26377109
DOI: 10.1136/bmj.h4629

No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility

Peter Doshi. BMJ. 2015.

. 2015 Sep 16:351:h4629.

doi: 10.1136/bmj.h4629.

Author

PMID: 26377109
DOI: 10.1136/bmj.h4629

No abstract available

PubMed Disclaimer

Similar articles

Putting GlaxoSmithKline to the test over paroxetine.
Doshi P. Doshi P. BMJ. 2013 Nov 12;347:f6754. doi: 10.1136/bmj.f6754. BMJ. 2013. PMID: 24222673 No abstract available.
Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
Hwang JP, Yang CH, Tsai SJ. Hwang JP, et al. Int J Geriatr Psychiatry. 2004 Feb;19(2):189-90. doi: 10.1002/gps.1051. Int J Geriatr Psychiatry. 2004. PMID: 14758586 Clinical Trial. No abstract available.
Odd odds.
Andrade C. Andrade C. J Clin Psychiatry. 2011 Nov;72(11):1558-9; author reply 1559. doi: 10.4088/JCP.11lr07373. J Clin Psychiatry. 2011. PMID: 22127198 No abstract available.
Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials.
Serretti A, Gibiino S, Drago A. Serretti A, et al. J Affect Disord. 2011 Jul;132(1-2):14-25. doi: 10.1016/j.jad.2010.08.018. Epub 2010 Sep 21. J Affect Disord. 2011. PMID: 20863574 Review.
Efficacy and tolerability of controlled-release paroxetine.
Golden RN. Golden RN. Psychopharmacol Bull. 2003 Spring;37 Suppl 1:176-86. Psychopharmacol Bull. 2003. PMID: 14566210 Review.

See all similar articles

Cited by

MedEdTrials: Protocol registration for medical education research.
Masters K. Masters K. MedEdPublish (2016). 2019 Jun 7;8:125. doi: 10.15694/mep.2019.000125.1. eCollection 2019. MedEdPublish (2016). 2019. PMID: 38440163 Free PMC article.
The Effect of Financial Conflict of Interest, Disclosure Status, and Relevance on Medical Research from the United States.
Cherla DV, Viso CP, Holihan JL, Bernardi K, Moses ML, Mueck KM, Olavarria OA, Flores-Gonzalez JR, Balentine CJ, Ko TC, Adams SD, Pedroza C, Kao LS, Liang MK. Cherla DV, et al. J Gen Intern Med. 2019 Mar;34(3):429-434. doi: 10.1007/s11606-018-4784-0. Epub 2019 Jan 2. J Gen Intern Med. 2019. PMID: 30604124 Free PMC article.
Incomplete and Curtailed Statements.
Mainz A. Mainz A. Dtsch Arztebl Int. 2018 Feb 23;115(8):133-134. doi: 10.3238/arztebl.2018.0133b. Dtsch Arztebl Int. 2018. PMID: 29526189 Free PMC article. No abstract available.
Benefits, harms and evidence - reflections from UK primary healthcare.
McCartney M. McCartney M. London J Prim Care (Abingdon). 2017 Oct 13;10(1):8-12. doi: 10.1080/17571472.2017.1384610. eCollection 2018 Jan. London J Prim Care (Abingdon). 2017. PMID: 29449890 Free PMC article.
TFOS DEWS II Clinical Trial Design Report.
Novack GD, Asbell P, Barabino S, Bergamini MVW, Ciolino JB, Foulks GN, Goldstein M, Lemp MA, Schrader S, Woods C, Stapleton F. Novack GD, et al. Ocul Surf. 2017 Jul;15(3):629-649. doi: 10.1016/j.jtos.2017.05.009. Epub 2017 Jul 20. Ocul Surf. 2017. PMID: 28736344 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information